Typhoid and paratyphoid fever: a clinical seminar - PubMed

Affiliations

• PMID: 33550411
• DOI: 10.1093/jtm/taab012

Review

Typhoid and paratyphoid fever: a clinical seminar

Abi Manesh et al. J Travel Med. 2021.

Abstract

Rationale for review: Enteric fever (EF) caused by Salmonella enterica subspecies enterica serovar Typhi (Salmonella Typhi) and S. Paratyphi (Salmonella Paratyphi) remains an important cause of infectious morbidity and mortality in many low-income countries and, therefore, still poses a major infectious risk for travellers to endemic countries. Main findings: Although the global burden of EF has decreased over the past two decades, prevalence of EF remains high in Asia and Africa, with the highest prevalence reported from the Indian subcontinent. These statistics are mirrored by data on travel-related EF. Widespread and increasing antimicrobial resistance has narrowed treatment options for travel-related EF. Ceftriaxone- and azithromycin-based therapies are commonly used, even with the emergence of extremely drug-resistant typhoid in Pakistan. Preventive measures among locals and travellers include provision of safe food and water and vaccination. Food and water precautions offer limited protection, and the efficacy of Salmonella Typhi vaccines is only moderate signifying the need for travellers to be extra cautious. Recommendations: Improvement in the diagnosis of typhoid with high degree of clinical suspicion, better diagnostic assays, early and accurate detection of resistance, therapy with appropriate drugs, improvements in hygiene and sanitation with provision of safe drinking water in endemic areas and vaccination among travellers as well as in the endemic population are keys to controlling typhoid. While typhoid vaccines are recommended for travellers to high-risk areas, moderate efficacy and inability to protect against Salmonella Paratyphi are limitations to bear in mind. Improved Salmonella Typhi vaccines and vaccines against Salmonella Paratyphi A are required.

Keywords: Salmonella Paratyphi; Salmonella Typhi; Enteric fever; antimicrobial resistance; travel; typhoid vaccines.

Similar articles

• Enteric fever and its impact on returning travellers.

  Dave J, Sefton A. Dave J, et al. Int Health. 2015 May;7(3):163-8. doi: 10.1093/inthealth/ihv018. Epub 2015 Mar 24. Int Health. 2015. PMID: 25808163 Review.

• [Typhoid and paratyphoid fever].

  Trawinski H, Wendt S, Lippmann N, Heinitz S, von Braun A, Lübbert C. Trawinski H, et al. Z Gastroenterol. 2020 Feb;58(2):160-170. doi: 10.1055/a-1063-1945. Epub 2020 Feb 12. Z Gastroenterol. 2020. PMID: 32050286 Review. German.

• Enteric fever: a travel medicine oriented view.

  Meltzer E, Schwartz E. Meltzer E, et al. Curr Opin Infect Dis. 2010 Oct;23(5):432-7. doi: 10.1097/QCO.0b013e32833c7ca1. Curr Opin Infect Dis. 2010. PMID: 20613510 Review.

• Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.

  GRAM Typhoid Collaborators. GRAM Typhoid Collaborators. Lancet Glob Health. 2024 Mar;12(3):e406-e418. doi: 10.1016/S2214-109X(23)00585-5. Lancet Glob Health. 2024. PMID: 38365414 Free PMC article.

• Typhoid and paratyphoid fever in travellers.

  Connor BA, Schwartz E. Connor BA, et al. Lancet Infect Dis. 2005 Oct;5(10):623-8. doi: 10.1016/S1473-3099(05)70239-5. Lancet Infect Dis. 2005. PMID: 16183516 Review.

Cited by

• Historic and Prehistoric Epidemics: An Overview of Sources Available for the Study of Ancient Pathogens.

  van der Kuyl AC. van der Kuyl AC. Epidemiologia (Basel). 2022 Oct 7;3(4):443-464. doi: 10.3390/epidemiologia3040034. Epidemiologia (Basel). 2022. PMID: 36547255 Free PMC article. Review.

• Clinical and Laboratory Features of Enteric Fever in Children and Antibiotic Sensitivity Pattern in a Tertiary Care Hospital of a Low- and Middle-Income Country.

  Nusrat N, Islam MR, Paul N, Rahman N, Krishnapillai A, Haq MA, Haque M. Nusrat N, et al. Cureus. 2022 Oct 27;14(10):e30784. doi: 10.7759/cureus.30784. eCollection 2022 Oct. Cureus. 2022. PMID: 36320797 Free PMC article.

• Emergence of Rarely Reported Extensively Drug-Resistant Salmonella Enterica Serovar Paratyphi B among Patients in East China.

  Peng J, Feng J, Ji H, Kong X, Hong J, Zhu L, Qian H. Peng J, et al. Antibiotics (Basel). 2024 Jun 2;13(6):519. doi: 10.3390/antibiotics13060519. Antibiotics (Basel). 2024. PMID: 38927185 Free PMC article.

• Changes in monocyte subsets in volunteers who received an oral wild-type Salmonella Typhi challenge and reached typhoid diagnosis criteria.

  Toapanta FR, Hu J, Shirey KA, Bernal PJ, Levine MM, Darton TC, Waddington CS, Pollard AJ, Sztein MB. Toapanta FR, et al. Front Immunol. 2024 Aug 27;15:1454857. doi: 10.3389/fimmu.2024.1454857. eCollection 2024. Front Immunol. 2024. PMID: 39263222 Free PMC article.

• Increased antimicrobial resistance among non-typhoidal Salmonella infections in international travellers returning to the Netherlands.

  Chanamé-Pinedo L, Franz E, van den Beld M, Veldman K, Pijnacker R, Mughini-Gras L. Chanamé-Pinedo L, et al. J Travel Med. 2023 Oct 31;30(6):taad079. doi: 10.1093/jtm/taad079. J Travel Med. 2023. PMID: 37294620 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • scite Smart Citations

• Miscellaneous

  • NCI CPTAC Assay Portal